ORG Wealth Partners’s Maravai LifeSciences MRVI Stock Holding History

ORG Wealth Partners’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$459	Buy	+60	New	+$415	﹤0.01%	2102

Other funds holding MRVI

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return

General American Investors New York $1.71B AUM 30.1% 1-Year Est. Return

Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return

ORG Wealth Partners's MRVI Position: Q3 2026 in Review

ORG Wealth Partners opened a new position in Maravai LifeSciences (MRVI) in Q3 2026: 60 shares worth $459. The stake represents ﹤0.01% of the portfolio and ranks #2102 among its holdings.

126 funds tracked by Wall St. Rank hold MRVI as of Q3 2026.

ORG Wealth Partners held 60 shares of Maravai LifeSciences worth $459 as of Q3 2026.
Maravai LifeSciences was a new ORG Wealth Partners position in Q3 2026.
Maravai LifeSciences made up ﹤0.01% of ORG Wealth Partners's portfolio in Q3 2026, its #2102 holding.
126 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2026.

Based on ORG Wealth Partners's 13F filing for Q3 2026, filed 3 Nov 2026.